Jeroen J A van Kampen

7PUBLICATIONS
44CO-AUTHORS
Disease surveillanceInnate immunityGene and molecular therapyPatient safetyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 02, 2025
Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 Cohort.

Kathryn S Hensley, Rob A Gruters, Els van Nood

|Mar 26, 2025
Computational and Population-Based HLA Permissiveness to HIV Drug Resistance-Associated Mutations.

Rizwan Mahmud, Zoë Krullaars, Jolieke van Osch

|Mar 12, 2025
HIV-2 EU-Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update.

Charlotte Charpentier, Dirk Berzow, Quentin Le Hingrat

|Jan 01, 2025
Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report.

Jeroen J A van Kampen, Els van Nood, Rizwan Mahmud

|Jul 29, 2023
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients.

S Reshwan K Malahe, Jeroen J A van Kampen, Olivier C Manintveld

|Mar 15, 2023
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.

Henrieke A B Prins, Raquel Crespo, Cynthia Lungu

Pageof 2